WaveMan · Form 4
Pace Gary W insider trades
> Search tickers & screens ⌘K
LIVE

Pace Gary W insider trades

Pace Gary W has filed 19 Form 4s with the SEC that we hold, for Cardiff Oncology, Inc. (CRDF) (Director) and Pacira BioSciences, Inc. (PCRX) (Director). Across all of them we count 10 purchases worth $3.2M and 6 sales worth $5.9M reported on Form 4. In the last 12 months: 2 purchases ($1.0M) and 0 sales ($0). The largest single trade was a sale of 90,000 shares of Pacira BioSciences, Inc. worth $2.8M, dated 2024-03-08. The first filing on our record is dated 2021-09-22 and the latest 2026-07-16.

Cardiff Oncology, Inc. (CRDF)

Director · 13 filings · 10 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-09-21P, purchase reported on Form 430,000$202.5K2021-09-22
2022-09-15P, purchase reported on Form 4150,000$256.5K2022-09-19
2023-11-10P, purchase reported on Form 422,950$22.5K2023-11-14
2023-12-19P, purchase reported on Form 430,000$41.1K2023-12-19
2024-12-11P, purchase reported on Form 411,500$29.9K2024-12-12
2024-12-11P, purchase reported on Form 4350,115$910.3K2024-12-12
2025-07-30P, purchase reported on Form 4275,000$673.8K2025-07-31
2025-07-30P, purchase reported on Form 415,000$36.8K2025-07-31
2026-06-18P, purchase reported on Form 430,000$36.6K2026-06-22
2026-07-14P, purchase reported on Form 4687,285$1,000.0K2026-07-16

Pacira BioSciences, Inc. (PCRX)

Director · 6 filings · 6 purchases and sales
Trade dateCodeSharesValue as filedFiled
2022-02-28S, sale reported on Form 428,641$1.9M2022-03-01
2022-03-01S, sale reported on Form 41,359$92.1K2022-03-01
2023-05-11S, sale reported on Form 45,015$209.5K2023-05-15
2024-03-06S, sale reported on Form 41,066$31.6K2024-03-08
2024-03-07S, sale reported on Form 428,257$870.6K2024-03-08
2024-03-08S, sale reported on Form 490,000$2.8M2024-03-08
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1184778) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms